Koyfin Home > Directory > Health Care > Rigel Pharmaceuticals > EV / Sales (ntm)

Rigel Pharmaceuticals EV / Sales (ntm) Chart (RIGL)

Rigel Pharmaceuticals annual/quarterly EV / Sales (ntm) from 2010 to 2020.
  • Rigel Pharmaceuticals EV / Sales (ntm) for the quarter ending December 12, 2020 was 5.22 a -0.71% decrease of -0.04 year over year
  • Rigel Pharmaceuticals EV / Sales (ntm) for the last 12 months ending December 12, 2020 was 5.22 a -0.71% decrease of -0.04 year over year
  • Rigel Pharmaceuticals Annual EV / Sales (ntm) for 2020 was 5.22 a -1.77% decrease of -0.09 from 2019
  • Rigel Pharmaceuticals Annual EV / Sales (ntm) for 2020 was 5.32 a 1.39% increase of 0.07 from 2019
  • Rigel Pharmaceuticals Annual EV / Sales (ntm) for 2020 was 5.24 a -0.35% decrease of -0.02 from 2019
Other Valuation Metrics:
  • Rigel Pharmaceuticals Market Cap for the quarter ending March 03, 2018 was $521m a 35.88% increase of 187m year over year
  • Rigel Pharmaceuticals Price / Book for the quarter ending March 03, 2018 was 5.16 a 23.02% increase of 1.19 year over year
  • Rigel Pharmaceuticals Enterprise Value for the quarter ending March 03, 2018 was $406m a 41.78% increase of 169m year over year
View Chart On Koyfin

Quarterly RIGL EV / Sales (ntm) Data

12/20205.22
12/20205.32
12/20205.24
11/20205.26
11/20205.41
11/20205.07
11/20205.06
11/20204.94
11/20204.74
11/20204.69

Annual RIGL EV / Sales (ntm) Data

20205.22
20205.32
20205.24
20205.26
20205.41
20205.07
20205.06
20204.94
20204.74
20204.69